Telomerase levels change in OFFER study

Published: 02-08-2017| Version 1 | DOI: 10.17632/csz5rw8fyk.1
Contributors:
Tomasz Pawelczyk,
Marta Grncow-Grabka,
Elżbieta Trafalska,
Janusz Szemraj,
Natalia Żurner,
Agnieszka Pawełczyk

Description

Changes in telomerase levels during 26-weeks supplementation of n-3 PUFA or placebo (olive oil) in first-episode schizophrenia patients.

Files